CSP Inc
NASDAQ:CSPI
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
9.0532
27.837
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
CSP Inc
Earnings Call Analysis
Summary
Q1-2025
The company reported a revenue of $15.4 million this quarter, a decline from $18.3 million in the same period last year. Contracts expected at the end of Q1 will instead bolster Q2 revenue. The gross margin fell to 26.6% from 31.7% due to lower-margin products, but there's confidence in expansion as the firm transitions to higher-margin offerings like AZT. Net loss of $73,000 contrasts to last year's $1 million net income. Despite a decrease in engineering costs due to reduced use of contractors and unfilled positions, SG&A expenses edged up slightly because of new sales hires and increased marketing efforts. With cash reserves of $25.6 million, the company looks to capitalize on a pipeline of over 500 prospects and embraces a subscription model for its software, aiming for robust monthly recurring revenue.
You don't have any saved screeners yet
Greetings. Welcome to the CSPi's First Quarter Fiscal Year 2024 Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded. I will now turn the conference over to your host, Michael Polyviou. You may begin.
Thank you, Holly. Hello, everyone, and thank you for joining us to review CSPi's Fiscal 2024 First Quarter Results Conference Call, which ended December 31, 2023. With me on the call today is Victor Dellovo, CSPi's Chief Executive Officer, and Gary Levine, CSPi's Chief Financial Officer. After Victor and Gary conclude their opening remarks, we will then open the call for questions. Statements made by CSPi's management on today's call regarding the company's business that are not historical facts may be forward-looking statements as the term is identified in federal securities laws. The words may, will, expect, believe, anticipate, project, plan, intend, estimate, and continue, as well as similar expressions, are intended to identify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results. The company cautions you that these statements reflect current expectations about the company's future performance or events and are subject to several uncertainties, risks and other influences, many of which are beyond the company's control that may influence the accuracy of the statements and projections upon which the statements are based. Factors that may affect the company's results include, but are not limited to, the risks and uncertainties discussed in the Risk Factors section of the annual report on Form 10-K and the quarterly reports on Form 10-Q filed with the Securities and Exchange Commission. Forward-looking statements are based on the information available at the time those statements are made and management's good faith belief as of the time with respect to future events. All forward-looking statements are qualified in their entirety by this cautionary statement and CSPi undertakes no obligation to publicly revise or update any forward-looking statements, whether as a result of new information, future events or otherwise after the date thereof. With that, I'll turn it over to Victor Dellovo, Chief Executive Officer. Victor, please go ahead.
Thanks, Michael, and good morning, everyone. Earlier this morning, we announced our fiscal 2024 first quarter results. However, before I ask Gary to review the quarter, I want to spend a few minutes highlighting 2 developments that were recently announced as I believe these truly demonstrate our growing business prospects and continued optimism with high-performance products in the Technology Solution businesses. To begin, the launch of the AZT PROTECT offering is and continues to be a game-changing development within the high-performance products, or HPP business, because the advancements allow us to offer our customers a giant leap forward in the evolution of cybersecurity solutions. A few days ago, we announced our largest and most significant contract to date for AZT, a multimillion-dollar agreement with a global pharmaceutical company deploying AZT across its global manufacturing operation technology, or OT, protecting over 40 facilities in response to the growing cybersecurity threat to OT from hostile nation states, terrorism and organized cybercrime. This customer appreciates the enormous risk of cybersecurity attacks on the facilities. It could lead to theft of intellectual properties, compromise safety and quality, regulatory fines, and major disruptions to its manufacturing process. However, many other remain extremely vulnerable and are ill-prepared to protect their critical assets from new wave of cybersecurity threats that can bypass network bypass protections in modern cloud-based next-generation antivirus solutions. The second development that was also recently announced was a 5-year multimillion dollar contract to provide managed services for a prominent Florida public college, one of the largest and most diverse institutions of higher education in the nation. We will deliver proactive monitoring, management, and support for college critical infrastructure including networking, security and private cloud services. I believe these 2 developments are a strong indicator of the future success and is precisely why the Board of Directors had the confidence to raise its quarterly dividend to $0.05 per share. I will spend a few moments highlighting the Technology Solutions or the TS business, and then I will focus the majority of my comments on the AZT offering as it has the potential to dramatically change our growth curve. The TS business performed as planned, and we continue to be excited about the current business as well as the leads being generated on a daily basis from new and existing customers. The TS business accounted for $14.7 million of the overall revenue and its success continues to be driven by our customers' increasing use of our implementation, installation, and training capabilities. As I stated on the last call, the UCaaS is becoming a profitable business, and we ended the fiscal first quarter with an increase in clients, and based on our current information and leads flow will continue to see an upward swing in the clients' activity as we move throughout the fiscal 2024. As many of you know, it's been a challenging business environment for several years and the team's ability to remain engaged with customers is amazing. I believe the yes, can-do attitude has enhanced our clients' loyalty because they recognize that our products and solutions are the most effective, cost-efficient answer to their critical needs. For example, while our cruise-related business has been relatively quiet during the following of the pandemic, the team has remained on the ready, and we are beginning to see some positive developments. For example, we received orders for several ships from one of the cruise line operators and the consistent growth of our non-cruise related shipping business is continuing as we currently are working with one of the largest freight operators specializing in containerized ocean exports serving numerous ports worldwide with an extensive global agent network and has become one of our larger MSP customers. Turning now to our high-performance products, our HPP business, my comments will focus solely on the emerging AZT offering as it continues to generate a significant amount of interest in the market that we believe will grow to over $50 billion based on the number of devices that need to be protected across the relevant verticals. We are excited about the industry's positive reaction to AZT. And we will remain bullish. Our sales funnel is getting larger and is attracting prospects across the Fortune 500. As a reminder, AZT's advancement allows us to offer our customers a giant leap forward in the evolution of cybersecurity solutions. AZT's performance surpasses what's available on the market today and its new generation of endpoint cybersecurity protection designed for critical operation technology environments. For example, and based on the internal testing, we believe AZT would have stopped solar wind Sunburst malware used during the attack after the initial breach. The unique tie-in solution protects aligned organization endpoints from a full spectrum of cyberattacks and attack techniques, including the most advanced zero-day attacks, malware, ransomware, supply chain vulnerabilities. Even those threats that are completely unknown to security teams. By deploying artificial intelligence capabilities, AZT automatically halts attacks before damage occurs, ensuring seamless operations without disruption or downtime. It lowers the risk of applications code-based vulnerabilities from exploit while running on endpoint devices to near zero. This removes the need for constant security patching updates and associated costs of production downtime. On the last call, I mentioned a number of industry events and conferences the team attended. And that each one, our name and reputation is growing, and we are garnering more and more attention. For example, Gary Southwell, CSPi's General Manager of ARIA Cybersecurity, recently hosted a webinar with retired Pfizer Global Head of Automation Engineering, Jim LaBonty. They discussed a wide range of challenges manufacturers face in today's new threat landscape. They delved into issues manufacturers need to address ranging from how to select the right technology to best practice to ensure critical manufacturing operations are protected. They focus on how current passive and active cloud-based security solutions are failing to guide against the new era of AI embedded attacks, creating substantial financial, regulatory, and reputational risk in manufacturing sectors such as pharmaceuticals. The webinar demonstrated how ARIA Cybersecurity's breakthrough solutions for OT environments would have stopped the solar winds attack and other recent high-profile attacks on critical infrastructure, where existing defenses have failed. We are planning additional webinars every quarter going forward. Additionally, we have -- we will be attending several conferences in the coming months, including the CS4CA manufacturing conference in Houston, and the DistribuTECH International Conference in Orlando. Our current customers are very chemical and natural security pharmaceuticals, demonstrating the breadth of our offering. In fact, there is no limit, no industry we can't access through our AZT offering given the wide range of needs of companies dealing with constant attacks on their enterprises. Our goal is to ensure the team remains focused and is able to deliver consistent results, which basically means it's just as important to pursue smaller transactions while still hunting elephants which can take up to several months to close. Additionally, we have continued to add resellers to leverage their knowledge, expertise, and customer depth to drive greater adoption of ARIA Zero Trust Protect, including the addition this week of a leading cybersecurity of ARIA's firm and reseller, which serves around 6,000 companies worldwide, including a focus on large enterprises in the world. To summarize, we remain cautiously optimistic and continue to position the company for greater success throughout fiscal 2024. We have 2 stellar businesses, the TS business, which has been the growth driver over the past few years, and the reemergence of the HPP through AZT offering is generating significant buzz throughout the organization and within the industry. With that, I will now ask Gary to provide a brief overview of the fiscal first quarter financial performance. Gary?
Thank you, Victor. For the first quarter ended December 31, 2023, we reported revenue of $15.4 million compared to $18.3 million in the year ago fiscal first quarter. The revenue could have been higher. That is if certain contracts were signed as expected towards the end of Q1. However, there were pushouts to the end of the year in the holiday season and signed contracts were signed earlier this quarter and will benefit fiscal Q2 revenue. Our Q1 gross revenue was $4.1 million or 26.6% of revenue compared to $5.8 million or 31.7% of revenue in the same prior year period. The decrease in gross margin compared to the year ago period as anticipated was due to the mix of business and the lower margin products. We continue to believe our gross margin will expand as the business transitions, especially the AZT offering, to higher-margin products and services. For the first fiscal quarter, our engineering and development expenses were $700,000, $173,000 lower from the year ago fiscal quarter as we reduced outside contractors and elected to not fill some open positions. Our SG&A costs for the fiscal first quarter was $3.7 million compared to $3.6 million in the year ago fiscal first quarter. The slight year-over-year-over-year increase is attributable to the addition of several salespeople and increased conference participation to help us raise awareness of the AZT offering. We reported a slight net loss of $73,000 or $0.02 per diluted share for the fiscal first quarter ended December 31, 2023 compared to the net income of $1 million or $0.21 per diluted share versus fiscal first quarter ended December 31, 2022. The company had cash and cash equivalents of $25.6 million as of December 31, 2023, compared to cash and cash equivalents of $25.2 million as of September 30, 2023. We believe our robust financial position allows us to be flexible and successfully implement our operating initiatives, and if necessary, leverage this to finance large customer agreements which have been highly successful in the past for CSPi. As Victor mentioned earlier, the Board of Directors approved an increase in the quarterly dividend to $0.05 per share, payable on March 8, 2024, to shareholders of record on the close of business on February 26, 2024. With that, I will turn it over to the operator to take your questions.
Certainly. [Operator Instructions] Your first question for today is coming from Brett Davidson with Investletter.
Good morning. Must be pretty satisfying to finally land that bigger deal?
Oh, my god.
And I'm thinking, too, so as far as salespeople, I know you added some in the past. Has that changed your thinking any? Is there plans to add more along the sales lines? Or are you guys pretty set right now?
No, we're interviewing other people right now. So we'll -- we plan on adding to that this quarter in the future.
Has it changed like the company's compensation philosophy? As far as share grants or kind of like tying these people to the prospects of the company overall?
All of that is on the table when we talk to these individuals.
Yes. I mean I'd love to see the people that are working there and selling this thing highly invested in the performance of the company. I think that would be just a great idea. And then a little bit on the revenue recognition of that contract the other day, how is that going to run through the income statement? Is that going to be all at once? Or is that going to be spread out over time?
That's all at once.
Okay, so that will drop this coming quarter? Nice. And last time we talked, I know that the cruise business was still kind of slow getting rolling here again. Has that changed at all? Is there any more progress on the cruise ship business?
Yes. We made some progress on a little different work than we've done in the past. I can't mention what kind of work we're doing with them, but it's -- we kind of moved into a new technology with the cruise line, and we're rolling it out to a bunch of ships. We won't have to travel as much as we used to in the past. We can do it a lot remote. But yes, it gave us a new form of income from these cruise lines that will be coming over the next couple of quarters.
And what does the size of that business look like?
It's in the hundreds of thousands.
Got it. And is this applicable to pretty much all the cruise lines? Or is this just like certain customers that still can take advantage of this?
No, every cruise line could do it, we're just not talking to every cruise line about it yet. Getting in front of them is half the battle.
Yes. Interesting. And that deal with the pharmaceutical company, I know you guys did not release the name of that. Are you guys able to use the name of that company when you are discussing sales with other potential customers?
With permission, yes.
So that is a possibility that you --
We have to ask permission, yes.
Yes, they are a referenceable account.
What was that, Gary?
They are a referenceable account, but we do need to get their approval on the accounts.
Got it. All right. Well, it was pretty exciting seeing those press releases. I hope to see more of them in rapid succession here.
As soon as -- as I said to numerous people numerous times, I don't hold anything back. Until -- I had said earlier, I thought the ink was close to being dry on some of them, but working with these large -- working with these large organizations, everything takes way longer than expected. Some of these things needed 10 signatures and getting 10 signatures I guess in a large organization is -- it takes months, not weeks.
Yes. Well, it's nice to have. No matter how confident you are in the product, there's always that lingering doubt in the back. It's nice to see that first big contract come through kind of confirming that your headed down the right path. It was --
Yes. Exactly. Exactly.
Yes. I'm very glad to see that. Glad that finally put behind you the big deal there and looking forward to plenty more. Great job. Bring everybody along with you.
Yes. We're trying. We're trying. Thanks, Brett. Appreciate your support.
Your next question is coming from Joseph Nerges with Segren Investments.
I just want to tell everybody that the annual meeting was very nice last week, and we had a -- from an investor standpoint, we had 100% increase in the attendance. That's the good news. The bad news, we went from 1 to 2 people at the annual meeting. I've been to annual meetings where we had a game-changing product and was standing room only. We're not there yet. But maybe the possibility down the road that we'll have standing room only at the meeting. A couple of quick things. I researched just briefly on your release of the pharma contract the Merck breach, which was breached a number of years ago. And just to let the market know here, the damages on the Merck breach, the insurance companies paid $1.4 billion. That's how much damage was done by that breach with Merck, so just to give you an indication of how much some of these OT environments are at risk when that type of a damage award can be out there. I don't know how -- do you guys know how the insurance is involved with these companies? I mean is there a separate policy for let's say the OT environment as opposed to the IT environment for breaches? Or is this kind of all rolled into one? Or do you not know that?
I have no idea, Joe. I have no idea how each --
Yes, I'm just saying, when you see that kind of -- I mean when you hit the OT environment, you could take down factories. I mean for an extended period of time, and so you could see where the costs could be quite dramatic. I don't know how these insurance companies work, but I imagine they are pressuring these companies to either provide better security or the premiums on the policy -- either there will be no policy or the premiums will be sky high on that type of award.
I can tell you, Joe, that just in our case as a small company, what we had to go just to get our cybersecurity. And in talking to the insurance companies, they're taking a very hard line on it. And you need tools such as we have to implement to help. Because if you don't have any protection, you don't get any insurance. They will give you nothing.
Well -- and that's I guess the point I'm trying to make. And of course, we're too early with the AZT PROTECT rollout to -- in other words, if you could become almost a best in breed for the OT environment, then there would be demand from either the insurance end or to protect yourself to the best you can. I'm just hoping that we can get ourselves known well enough that the companies, even the insurance companies, begin to recognize the benefits of the AZT PROTECT product. We'll see how that goes down the road. A couple of things at the annual meeting you mentioned. One was your intellectual property. I think you said, Victor, that there was -- that we have 2 patents awarded. And what do we have, 6 or 8 more pending? Is this -- I'm trying to recall what you said on that.
6 total. 2 that are already approved, 2 that are in the last waiting stage. I think if my memory serves me right, I think it was supposed to be February, March somewhere. It's the waiting stage of just making sure no one has any issues. And then 2 that are in more of the --
Longer term.
Review. The review process.
And I assume almost all of it is tied to the ARIA platform, right? Or the --
It's all the AZT. It's all 6 are on it, yep.
Okay. A couple of things. I did ask you 2 on R&D, what are we doing? And I think you said we're in beta tests now. We're expanding the software to Android devices out there. Is that what you're saying? We're testing the --
Yes, it's on the road map, yep. Android is on the road map.
And I think you were adding to even the screen capability, where multiple screens can be reviewed by some of these managed service providers at one time?
Yes. It's on the roadmap. Yes. It's on the road. We're still in the development.
Yes. I don't think a lot of people out there realize that when you introduced AZT PROTECT in July, we weren't on Version 1. We were on multiple versions, we had gone through multiple versions before we came out with that. It wasn't like it was the first version that came out there. And since then, of course, you added the Linux, right? I don't know what version you're in. Do you know what version we are in now on the AZT PROTECT product? I mean we must be 6 or 7 now.
No, I think we're on like 13.
Really?
I think, yes.
Say that again. Sometimes when most people come out with a version, it's 1.0. But we're not there. We've advanced this over the number of years pretty extensively.
Yes. I think I had mentioned before that our original goal was to get a version out and then add a lot of the functionality and the bells and whistles as we moved along. But through one of our large customers that we've talked about, they needed all the functionality immediately before they were willing to sign off on it. And that's kind of why it took a lot longer for the development and truly the first release that was available to sell was in this past July.
Wow, perfect. The end result was a more robust product when we finally came out with it. And I'm assuming that what we built, it can be utilized almost across the board on any industry like you said. Okay. One thing, on this major reseller agreement you just signed a contract, is that one -- was that -- you talked the last time about 2 major system integrators. Was this the contract that was just signed 1 of the 2? Or is this a separate group altogether?
No, it's a separate group.
It's a separate group. We were talking about other major integrators that we haven't -- I think you had 2 the last time. Is this now 3 or --
Yes. We're I think about half a dozen of I would say decent size integrators. There's a couple that are real -- this is annual sales in the billions.
And just a quick point on this. When you signed the contract, what's different with the contract versus what you're talking to the others? I mean is there any performance requirements in the contract for the reseller? Or is it just a contract that any one of them could have signed a contract of the number you're talking about?
Well, let's face it, anybody can sign it, but some of these larger ones because they're quoted by every product out there, they only bring on new products where they believe A), there's a gap. And then of course too, that there's a big -- there's a certain amount of revenue they can get from a product line, right? It's not -- onetime sales is something that they're not looking for. It took I would say at least 6 months to go through the process with them of them looking at the product and then also bringing our product into some of their customers and talking about it and getting feedback and looking at a real need that's out in their customers' environments. And that's kind of what brought it over the finish line to get the contract signed was that they believe there's enough for their customers that can look at this product. They're not guaranteeing anything of course, but if there's truly a need and a gap and we are talking I would say at least a half a dozen of their customers already in different stages. We're hoping -- they have a lot of customers. I think that the target that we looked at is somewhere over 500 potential customers that we can at least talk to that may have a need of some sort for AZT.
Okay. Well, that's great. I mean it's a huge market to expand. Just one other point, and you brought this up at the annual meeting, you talked about that you get -- you often get calls down there in the TS group for people that are after -- are looking to buy either the TS group or buy into our managed services. In other words, offerings. They want to buy our managed service offerings. Has any of those talks ever reached a dollar? Or have you just not advanced those talks at all, we're not interested?
No, we're just concentrating on building the business.
Okay. But you have fielded calls or people want to know if we're even in the market to sell is what you're saying?
Yes. It's a lot of e-mails, and there's a few people that actually catch me picking up the phone that I have conversations with. But right now, it's just about building that monthly recurring revenue.
Yeah, the talks have never progressed is what you're saying other than just a pure interest that people are floating some questions out there to see if we're interested at all. Well thanks a lot, appreciate it. It seems like we're -- just a matter of time to get some of these big numbers across the board for AZT. Thanks, guys.
Your next question for today is coming from Will Lauber with Visionary Wealth Advisors.
Can you -- there's been some confusion on our end how the AZT product is being priced. Is that a monthly recurring subscription?
Yes. Moving forward with the customers, it is a monthly recurring. Gary had mentioned that this one is upfront. And we made an agreement with the pharmaceutical organization, just because they helped us test it for 18 months, that they could purchase it upfront as a onetime fee with yearly maintenance after that. But moving forward, it will be more of like a crowd strike model where it's a monthly recurring.
Okay. And is that priced by site or --
Per user. Per user. Per endpoint I should say, which -- we're in the -- we're not truly end user as laptops were in the server as the endpoint because we're protecting the application. If there's a server with 10 VMs, it would be basically 11 licenses for that. If you have 1,000 servers, you can do the math on that.
Okay. And I guess one of the things that I noticed in this latest release compared to some of the early ones I guess in particular, that Fortune 500 chemical company, I think that was just for one site. Does this pharmaceutical company, does that include like all their manufacturing sites? Or is there still some that could be -- come on later?
Yes. This is -- I'm hoping it's just the first phase. No guarantee, but once we roll these out, then we'll see what's next.
And then with that full manufacturing company, how are things going with that? Or does that have to be -- is it each plant manager that has to make the decision to add that? Or how is that?
On which company is that?
The chemical company.
Yes, we unfortunately have to deal with each and every location separately. Where the pharmaceutical, this is being pushed out from a corporate level, it's a little easier for us to deal with this rollout than the other one. It's been challenging, but it's a process.
It's in one facility now. What's the potential with that customer? How many facilities?
I want to say there's 80 sites.
All right. And have you guys been seeing any increased interest from the SEC rule about cybersecurity? Or how is that kind of playing out?
We're using it as a sales -- it's out there and we're talking about it. Every time we talk about it, it's one of our selling points. Not only the protection, but what could happen if you don't.
Your next question is coming from Mike Price, a shareholder.
I appreciate the press releases, but they're pretty vague. All of them have said multimillion dollar, and there's no way for us to evaluate what the impact is going to be to revenues. And you said that you could use the buyer of the AZT as a reference in trying to secure new buyers, but what about publicly disseminating who a buyer is? It seems like it's in everybody's best interest, with their permission. It gives credibility to CSPi. And for the customer, it seems like putting up a sign in front of your house saying I'm protected by this security, and that's almost a deterrent.
It works opposite. If they know what it is, then they could potentially know what to do, how to hack. Too, we don't have permission. It's right in the contract, we cannot use their name. That was part of the terms and conditions. Too, we can use it on as I said a permission basis. Basically calling the customer up, saying I have this customer, they would like to talk to you, they would like to have a reference, are you willing to speak with them? And if they say yes, then we can set up the call, and then we can move forward. Any time I can use someone's name legally, I would do it. If I didn't, it's for a reason.
Okay. On the last conference call, you said you were in discussions with 50 potential buyers of AZT. Can you give us an update on that?
Yes, some have progressed. There's some that are moving. Again, I don't want to state it again, because then after I've got you guys driving me crazy on exactly. We're talking contracts, but when that is, I have no idea. But yes, they're all progressing. Some sell off. Some of them said, we love it, we don't have budget for 6 months. It's a normal sales game. But some fall off, some come in. And we're setting -- the shows did well for us. We have multiple POCs that came from the shows where they have the product, they're testing it. And after the testing, then we'll see how long it takes to close the deal. But there are some progressing in that. We have a couple of more shows coming up in March, which as they come up and they're -- we believe that it's the right audience, we'll be attending them.
Okay. And if a reseller actually places, sells AZT, is this something that you'll disseminate to the same as you have when you sell it yourself?
Correct. Correct. Yes. Exactly.
Okay. And I asked this question each of the last 2 conference calls about buying stock. Did you buy back any stock last quarter?
No, the company did not. I personally bought some stock again last quarter.
I saw you bought it. It was down $5, it couldn't have been better timing. And again, we had the same issue today with the stock down almost $3 and down more earlier. And with the roadway that you paint for us, it still seems like a good use of shareholders' cash. Appreciate the increase in the dividend, but it seems like a good use of cash going forward. It seems like there's quite the runway here. One final question. Any thoughts about changing the name of the company? I mean the company is definitely going towards cybersecurity, ARIA Cybersecurity?
That's why we have ARIA Cybersecurity under the umbrella of CSPi because they still have the other business, the TS business.
Your next question for today is coming from Sergio Heiber with Heiber Research.
Congratulations on the progress that you're making. I'm wondering about -- I understand that you can't disclose the customer without the customer's permission, but why can't you disclose the amount of the contracts?
Because we normally -- we don't give -- we never have given exact amounts of contracts and what they are. We'll disclose the next quarter when we actually recognize it.
It's difficult for investors to put a price on the stock without knowing how much the contracts are. And that's why I ask. And you're not giving any guidance. Are there plans to provide guidance in the future?
Potentially, but not right now.
Is the reason that you're not giving out the amount of the contracts because of competition? Not to give away to the competition what the product sells for?
That's part of it, yes.
Okay. And then I have a question from a reader from my Seeking Alpha article. And I figured I'll pose it to you. I don't know how to answer this question, and I don't know if it's a fair question. But the companies and the enterprises that you're selling the AZT product are large and entities that have their own IT department. Why would they be customers of you instead of developing the product for their IP?
They want to develop a security product through their own IT? Okay, that's possible I guess. With enough money, time and expertise, anybody could potentially do it. But if he's asking if they have their own IT department or if someone who doesn't have their own security department, could we help manage that for them, the answer is yes. But whether you have your own IT department or not, you still need some type of product to do the inspection in the protection and the detection and everything else that goes along with that. But I'm a little confused on what he's asking.
Look, I couldn't answer the question either. And it came from more than one person. Basically, I don't think that the average person, including me, understands the complexity of security and there's so many products out there, and we're trying to figure out how do we know that there is nothing else like this product and how disruptive it is. How can we judge that? I've asked experts in the field and they can't answer the question. And I think investors are trying to figure that out.
I think I've mentioned on calls, it's a crowded space. Everybody knows the big boys. The Palo Altos, you name it. Then there's a second tier which I don't know exactly the number, but a couple of years it was over 2,000 other security companies of all sizes. Of course, it's a crowded space, how do you separate yourselves? That's a challenge that we have to deal with every day. Winning this contract, that's going to be our biggest selling tool. Because when you looked at the company we sold to, they tested everything. They have the resources. God knows it took us over 18 months to close this deal. They have the option and everybody out there security-wise was knocking on their door. They had the option to look at many, many products. And for them to choose our product after the literally over year testing, that's kind of how where we believe our product does fit a need. It's not just from -- of course, some of the people on the phone have heard this, we think our baby is beautiful, but it may not be. But having these customers test the product, look at it and it fills a need, especially with the later XP Windows, the older versions. These -- all these other companies are really not supporting the old versions of Linux and Windows. Not only we can do the current ones, but we can go all the way back. And as -- I suggest everybody who's on the call, go back to the webinar that we did. It really breaks down the value of the product, why we're different, and how we complement other existing products. I think Jim LaBonty mentioned on the webinar that if you look at like a Clarity or a Crowd Striker, they have -- they're necessary, but there's a void. And we can fill that void. Now you can use us exclusively if you want, that's beautiful and we'll take it, or we can complement the existing products that are out there to fill a gap. There's some products that they'll detect, but they won't prevent. And that's kind of where we step in and we do zero day attack on zero day. Not oh my god, I've got to go patch it, give me a week or 2 days or 5 days or 6 months to go patch it. Our biggest issue is we need to get the message out, and we're doing everything we possibly can to talk to as many customers and to evangelize that message. Give us a chance to show our product, do a POC, beat it up and let us show you the performance of the product.
Thank you for that. I think you guys are making great progress considering the product hasn't been out a year yet. When will we start seeing revenue from AZT?
Next quarter.
And is that the pharmaceutical contract?
Yes. And we're hoping that there'll be other customers that will fall into place. But there's like 2 more -- like I told you, you're going to hear a big bang from the pharmaceutical because the way we sold it to them is that onetime deal. And then all the other customers, we want to sell them as a monthly recurring revenue to build up that model.
Excellent. And will there be upfront fees on the recurring revenue?
Well, it just depends. If they want us to do the install, then we're going to charge professional services for that. And then you'll do a monthly fee and per endpoint, and that will include the maintenance in that monthly fee too, so they'll get all the latest and greatest updates that we have.
We have time for 2 more questioners. Your next question is coming from Paul Scolardi, a private investor.
Awesome job on the quarter. Awesome job with the press releases. I want to start off by saying that.
Thank you.
Can you hear me?
Yes, I can hear you perfectly.
Yes, I kind of feel bad that you have to deal with these rookie questions from shareholders because it's common knowledge that smaller companies cannot release either the name of larger company deals or the amounts for strategic reasons. But I, as a shareholder, and most shareholders, appreciate that you're still giving great full press releases once you get these deals to keep the Street informed. I say great job with the press releases. And also, if the prior caller would have listened to that awesome webinar with the ex-Pfizer executive, he said the differentiation of the AZT product out in the marketplace. That webinar was awesome information. I think first, some of the shareholders, you need to do a little more research before you waste the executive time with these questions. Now for a few questions, and I'll be brief because you guys did an awesome job. We're seeing on a macro level in recent weeks, headlines coming out about China, Iran, Russia that they're going to attack the infrastructure. We saw in recent months that water infrastructure in the United States was actually attacked. This seems to be brewing as an emerging scary theme, that one, doesn't this place even more massive importance and imminence on the AZT product? And are those type of headlines, do you see them as being A), as obviously a selling point? And do you think they're going to raise awareness for these companies to start seeking to protect their OT environment?
I would think so. Joe actually was -- Joe Nerges, every morning I get the latest and greatest releases of every breach that happens. At like 4:00 A.M., he sends them out to me. And we use that. I forward it to the salesforce. How people say, we don't have budget for the security when they know they have a gap, I have no idea. I literally on every sales call, if that comes up, I'm like, I just don't believe it. Because getting hacked is only a matter of time. It's not if you're ever going to, it's someway, somehow, somebody will get some type of hack inside the organization. I don't know if it's 3 years from now, 2 years, but it's going to happen of all sized companies, so how people are not making security their #1 priority? And the thing is, like good enough is not the right answer. Because it only takes one access point inside the network or the infrastructure and then they're in. Saying I'm 90% protected is not the right answer for these organizations. How this doesn't just fly off the shelf I'm not sure because I believe we're doing a really good job separating ourselves from the rest of the group out there. But it's still CSPi, who are we? And we're trying to -- like I said, we're trying to do the shows, we're trying to do the webinars, we're trying to get in front of many customers. We're trying to bring on resellers. And unless the product speaks for itself, that's what we try to position. You can listen to us all day long. Let us do a POC, let's run the product in your environment, and let the product speak for itself. And we've never got that feedback from any customer that's taken the time to look at it.
Right. No, 100%. And in many ways, like according to the damage of the hack, the product pays for itself if you think about how much it's going to cost to get hacked. And I think really what we need is to get you on CNBC or FOX News, Business News when they have all these scary headlines, to say AZT has the solution. And hopefully, maybe we'll see that soon. Next like we talked about mandates, and we know there's an SEC reporting mandate. I think Australia has a mandate. Does the U.S. and other countries have these growing mandates to have this OT protection? And is that kind of you see something that's going to drive more awareness to AZT? The mandates themselves, are you seeing that? Are people saying, hey, we've got to get this in place, whether it be the U.S. or other countries?
People are talking about it. If they're not, we're bringing it up. Like I had mentioned earlier, we're using that as one of our key selling points. Like it's not going to be a choice any longer. You're going to have to do this. And it all becomes about just getting time in front of the customers. Once you have some time with them, you can peel back the cover to see where their need is and then it's our job just to sell it to them and show them the value. But yes, I believe the mandates, they can't hurt. They can only help.
Yes. Okay. And then also, we talked about last call about cybersecurity company partners potentially and talking to them. And we know that there is a press release showing that NVIDIA is a current partner. Now I know companies like NVIDIA are very secretive and you might not be able to tell me anything about it, but it is public info that they are a partner. Are they partnering on the AZT side? And are you still in talks with other big cybersecurity players to potentially sell this for you since it doesn't compete and it could just be an add-on product to like a Palo Alto's offering?
Yes and yes. We are still talking to NVIDIA heavily, weekly, and we are still talking to other major players out there to partner with them to make our offering as a -- selling as a bundled product.
Awesome. That's great. Thank you for that. And lastly, my last quick point is you guys are doing an amazing job on executing, both you and Gary and the whole company. We want that as shareholders. But it would be nice when CNBC and everybody is talking about the cyber threats for operational technology, if we could get you on CNBC. Have you thought about hiring like an investor relations/public relations firm? Since one of our biggest -- this is like the -- I feel like -- the Super Bowl just happened. CSPi is at the Super Bowl, but nobody knows they're playing in it yet. Have you thought about hiring an IR/PR firm so while you guys are busy executing somebody can help get the story out from a marketing shareholder perspective? Which is also -- it's not the most important thing, execution is more important, but it's part of the equation.
Yes, we are. We are talking about it, and we're -- there's a game plan.
No, that's good. As long as you guys are -- it's on your plate and you're thinking about it. I just want to say, because I was more intense last quarter, you guys have done an awesome job. I appreciate the press releases. Keep them flowing. And to me, this is like a generational opportunity. And with the headlines, the scary macro headlines we're seeing, this is like a much needed product for so many companies and governments. Thank you, guys, and great job.
Your final question for today is coming from John Crotty, a private investor.
Just want to say congratulations on a great quarter. You guys actually accomplished everything you said you were going to do in the last quarter. Some of it might not have been as timely, like the ink drying, but you did it, so that's actually a big kudos to see management actually do what they say they're going to do. And the other thing is there's great information on this CC and every retail investor should listen to this. Most importantly, when Joe mentioned the $1.4 billion cost to Merck, I mean those are amazing numbers. You think everyone would realize when their insurance company won't cover it, they should be calling you guys. I mean -- but anyway, here are my questions. We know, and I anticipate your phone to be ringing off the hook, but I know you have a lot of resellers. Like we saw you guys with a deal down in Florida in a pre-existing MSP customer. Any feedback from any of your resellers? Especially the large one in Australia, and they do have a mandate as well. And just about the other like 50 smaller partners you have regarding these large ones, any feedback? Are you assisting them? Are they needing any assistance?
Well, there's 2 separations. The reseller -- the TS division is the one that sold the MSP contract, so that's all part of the CSPi umbrella. And then you have all the other resellers that we signed under the ARIA division, the HPP division. Those resellers are the ones that we're targeting with AZT. And those are the new contracts that we signed with the large reseller. And it's about training them, doing marketing events with them. Those are the things that we're doing with those types of resellers. But there's -- it's really -- no one has really put 2 and 2 together or asked us any questions about the MSP contract or anything else we won. That's why we separated the 2, so all the information that we're dealing with, with the ARIA, stays separate so those resellers feel comfortable that all their information is private.
Okay. You're doing that on behalf of the pre-existing partnership side of the deal. What about like the Logitech that's been strictly an AZT reseller over in Australia? And again, they have a mandate. Just wondering what they're seeing and if they may be equivalent to you.
Yes. He's coming -- he deals with a lot of government entities out there in Australia. As you know, things work slow, but it's about getting in front of them with the POCs and then he does the rest of the work. We educate them, we train them. He has a lab. Everything that he needs to be successful, he has, and now it's about him just working the relationships and the opportunities that he finds out in Australia.
Okay. And my last question has to do with the type of product or company mix you're seeing with your leads. Are they more government? Are they more infrastructure like electrical, oil and gas? Or are they more like manufacturing, like you just recently won? Or higher ed even?
Oil and gas is definitely a segment that we're talking to quite a few people. The pharmaceutical area, medical, those are probably the 3 top ones that we're talking to right now.
Okay. Fair enough. Okay. No, that was it, just trying to get a good mix. All right, guys, thank you so much and look forward to next quarter and attending the meeting as well.
We have reached the end of the question-and-answer session, and I will now turn the call over to Victor for closing remarks.
Thank you. As always, I want to thank our shareholders for your continued interest and support. We are entering a period of increased activity and we look forward to sharing our progress on the next fiscal 2024 second quarter in May. Until then, be well and stay safe.
This concludes today's conference, and you may disconnect your lines at this time. Thank you for your participation.